查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1989126

口腔微生物组市场预测至2034年－按产品类型、技术、应用、最终用户、通路、人口统计和地区分類的全球分析

Oral Microbiome Market Forecasts to 2034 - Global Analysis By Product Type, Technology, Application, End User, Distribution Channel, Demographics, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，预计到 2026 年，全球口腔微生物组市场将达到 11.4 亿美元，在预测期内以 15.9% 的复合年增长率增长，到 2034 年将达到 37.1 亿美元。

口腔微生物组市场专注于了解和调控口腔内复杂的微生物生态系统，以改善口腔和全身健康。科学知识的进步揭示了口腔细菌与全身性疾病之间的联繫，这些疾病不仅包括牙周病，还包括心血管疾病、糖尿病和阿兹海默症，这正推动着标靶治疗和诊断技术的创新。这一新兴领域涵盖益生菌製剂、诊断测试、基于微生物组的治疗方法以及旨在维持微生物平衡的专用口腔清洁用品。

越来越多的科学证据显示口腔健康与全身性疾病有关

随着越来越多的研究显示口腔微生物群组成与整体健康密切相关，口腔微生物群市场的重要性正超越牙科护理的范畴。研究表明，牙周病原体与心血管疾病、不良怀孕结果和呼吸道感染疾病之间存在关联，这为消费者和医疗保健专业人员重视口腔微生物平衡提供了强有力的理由。这种更广泛的健康视角将口腔清洁用品从单纯的美容问题提升为重要的健康维护措施，从而推动了对支持有益菌丛产品的需求。医疗保健专业人员越来越多地推荐注重微生物群的口腔清洁用品产品，并透过专业管道和相关人员扩大市场覆盖范围。

产品分类中的监管复杂性

口腔微生物组产品监管政策的不明确是其市场准入的一大障碍，也为商业化带来了许多挑战。根据功效声明和配方，调节微生物组的产品可能被归类为化妆品、膳食补充剂、医疗设备或药品，而每种产品都需要不同的核准流程。这种监管上的模糊性增加了研发成本，延长了产品上市时间，并为生产商带来了合规风险。国际监管标准的不统一进一步加剧了全球商业化策略的复杂性。尤其是小规模的创新公司，即使拥有强有力的科学证据和消费者兴趣，也难以满足这些复杂的监管要求，这可能会限制产品多样性并减缓整体市场成长。

将人工智慧整合到微生物组分析中

人工智慧驱动的平台能够分析复杂的口腔微生物组数据，为个人化口腔清洁用品建议带来创新机会。机器学习演算法可以识别与特定疾病风险相关的微生物模式，从而实现预测性诊断和标靶干预。这些技术能够处理来自定序和代谢体学的大量资料集，为消费者和牙科专业人士提供可操作的见解。人工智慧的整合加速了基于微生物组的疗法的伴随诊断的开发，从而实现即时治疗优化。随着运算能力的提升和成本的降低，人工智慧驱动的个人化口腔健康解决方案正变得越来越普及，为更广泛的用户群创造了巨大的市场拓展机会。

传统牙科专业人士的怀疑态度

传统牙科专业人士的抵触情绪会影响患者的认知和治疗建议，进而威胁市场渗透。许多牙科专业人士对微生物组科学并不熟悉，或对益生菌口腔保健方法持怀疑态度，更倾向于采用现有的机械和化学干预措施。这种怀疑态度限制了专业人士的推荐和转诊，进而显着影响患者对新产品的接受度。如果得不到牙科界的支持，微生物组产品可能会被视为缺乏依据的健康潮流，而非循证治疗方案，从而阻碍市场渗透，并延缓其融入标准口腔清洁用品通讯协定和专业建议的过程。

新冠疫情的影响：

新冠疫情提高了人们对免疫健康与微生物平衡之间联繫的认识，从而带动了口腔微生物组市场的发展。消费者越来越意识到口腔是病原体进入人体的途径之一，因此对增强口腔免疫力的产品需求日益增长。疫情封锁期间远距牙科服务的普及，使患者熟悉了远端口腔健康管理，也为推荐以微生物组为基础的产品创造了管道。然而，疫情导致的牙科就诊中断，暂时减少了专业人士提供样品和建议的机会。从长远来看，消费者对预防性口腔健康管理的持续关注以及对数位化医疗方式的接受度，都将推动市场持续成长。

在预测期内，口腔护理产品细分市场预计将占据最大的市场份额。

在预测期内，口腔护理产品预计将占据最大的市场份额。此细分市场包括牙膏、漱口水以及旨在支持口腔有益菌丛的特殊配方产品。这些产品在保留传统清洁功能的同时，融入了有益于口腔微生物群的成分，使消费者能够在不改变现有习惯的情况下提升口腔护理效果。领先的口腔护理品牌正透过利用其成熟的分销管道和消费者信任，并拓展产品线，进军这一细分市场。该细分市场凭藉其日常使用习惯和广泛的受众群体而占据优势，随着微生物组科学融入传统口腔护理，有望保持其持续的市场领导地位。

预计在预测期内，次世代定序（NGS）领域将呈现最高的复合年增长率。

在预测期内，次世代定序(NGS) 技术预计将呈现最高的成长速度，从而以前所未有的精度和深度对口腔微生物组进行全面分析。 NGS 技术能够识别与健康和疾病相关的细菌种类和菌株，为诊断应用和治疗方法的开发提供支援。定序成本的不断降低使得这项技术越来越容易应用于临床和直接面向消费者 (DTC) 的领域。牙科专业人士正在利用基于 NGS 的检测来制定个人化的治疗方案，而研究人员则正在使用这些工具进行微生物组探索。该技术在推进诊断和治疗方面发挥的关键作用，正是其显着增长的驱动力。

市占率最大的地区：

在预测期内，北美预计将占据最大的市场份额，这得益于其先进的牙科医疗保健基础设施、较高的消费者意识以及对研发的大量投入。该地区拥有领先的微生物组研究机构和许多致力于将科学发现商业化的创新Start-Ups。强大的D2C（直接面向消费者）行销管道以及消费者对新型健康产品的接受度正在加速市场渗透。牙科保险对预防保健的覆盖范围以及专家对微生物组相关产品的推荐，进一步促进了产品的普及。研究人员、临床医生和製造商之间建立的稳固关係，构成了一个创新生态系统，这将使北美在整个预测期内保持市场主导地位。

复合年增长率最高的地区：

在预测期内，亚太地区预计将呈现最高的复合年增长率，这主要得益于其庞大的人口基数、不断提高的口腔健康意识以及中产阶级获得高品质口腔清洁用品的管道日益增多。在中国、日本和韩国等国家，传统的预防医学概念与先进健康技术的快速普及相结合，同时，随着牙科旅游的兴起和国际讯息的广泛传播，消费者对微生物组概念的了解也日益加深。政府促进医疗保健的措施以及不断增长的医疗保健支出，都为市场基础设施​​的建设提供了支持。随着国际微生物组公司拓展经销伙伴，以及本地製造商开发针对该地区的产品，亚太地区正崛起为成长最快的区域市场。

免费客製化服务：

所有购买此报告的客户均可享受以下免费自订选项之一：

  • 企业概况
    • 对其他市场参与者（最多 3 家公司）进行全面分析
    • 对主要企业进行SWOT分析（最多3家公司）
  • 区域划分
    • 应客户要求，我们提供主要国家和地区的市场估算和预测，以及复合年增长率（註：需进行可行性检查）。
  • 竞争性标竿分析
    • 根据产品系列、地理覆盖范围和策略联盟对主要企业进行基准分析。

目录

第一章：执行摘要

  • 市场概览及主要亮点
  • 驱动因素、挑战与机会
  • 竞争格局概述
  • 战略洞察与建议

第二章：研究框架

  • 研究目标和范围
  • 相关人员分析
  • 研究假设和限制
  • 调查方法

第三章 市场动态与趋势分析

  • 市场定义与结构
  • 主要市场驱动因素
  • 市场限制与挑战
  • 投资成长机会和重点领域
  • 产业威胁与风险评估
  • 技术与创新展望
  • 新兴市场/高成长市场
  • 监管和政策环境
  • 新冠疫情的影响及復苏前景

第四章：竞争环境与策略评估

  • 波特五力分析
    • 供应商的议价能力
    • 买方的议价能力
    • 替代品的威胁
    • 新进入者的威胁
    • 竞争公司之间的竞争
  • 主要企业市占率分析
  • 产品基准评效和效能比较

第五章 全球口腔微生物组市场：依产品类型划分

  • 含有益生菌的口腔清洁用品
  • 益生元口腔清洁用品
  • 共生製剂
  • 口腔微生物组诊断与检测套组
  • 以微生物组为基础的疗法
  • 口腔清洁用品
  • 营养补充品
  • 其他产品类型

第六章 全球口腔微生物组市场：依技术划分

  • 次世代定序（NGS）
  • 总体基因体学
  • 宏转录组学
  • 蛋白质体学和代谢体学
  • 生物资讯学和微生物组分析
  • 人工智慧驱动的微生物组建模
  • 其他技术

第七章 全球口腔微生物组市场：依应用划分

  • 预防蛀牙
  • 牙周病
  • 口臭治疗方法
  • 口腔癌检测和风险评估
  • 与系统性疾病的关联
  • 个人化口腔护理
  • 预防牙科
  • 其他用途

第八章 全球口腔微生物组市场：依最终用户划分

  • 牙医诊所
  • 医院
  • 研究和学术机构
  • 诊断检查室
  • 製药和生物技术公司
  • 个人消费者
  • 其他最终用户

第九章 全球口腔微生物组市场：依通路划分

  • 线上平台
  • 药局和药局
  • 牙医诊所和医院
  • 专卖店
  • 直接面向消费者的销售管道
  • 其他分销管道

第十章 全球口腔微生物组市场：依人口统计群划分

  • 成人
  • 儿童
  • 老年人口

第十一章 全球口腔微生物组市场：依地区划分

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 比利时
    • 瑞典
    • 瑞士
    • 波兰
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 马来西亚
    • 新加坡
    • 越南
    • 其他亚太国家
  • 南美洲
    • 巴西
    • 阿根廷
    • 哥伦比亚
    • 智利
    • 秘鲁
    • 其他南美国家
  • 世界其他地区（RoW）
    • 中东
      • 沙乌地阿拉伯
      • 阿拉伯聯合大公国
      • 卡达
      • 以色列
      • 其他中东国家
    • 非洲
      • 南非
      • 埃及
      • 摩洛哥
      • 其他非洲国家

第十二章 策略市场资讯

  • 工业价值网络和供应链评估
  • 空白区域和机会地图
  • 产品演进与市场生命週期分析
  • 通路、经销商和打入市场策略的评估

第十三章 产业趋势与策略倡议

  • 併购
  • 伙伴关係、联盟和合资企业
  • 新产品发布和认证
  • 扩大生产能力和投资
  • 其他策略倡议

第十四章：公司简介

  • Colgate-Palmolive Company
  • Procter & Gamble Company
  • Johnson & Johnson
  • GlaxoSmithKline plc
  • Unilever PLC
  • 3M Company
  • Dentsply Sirona Inc.
  • Kao Corporation
  • Lion Corporation
  • Sunstar Suisse SA
  • Oragenics, Inc.
  • BLIS Technologies Limited
  • Oral Biotech Ltd.
  • Microbiome Insights Inc.
  • Viome Life Sciences, Inc.
Product Code: SMRC34415

According to Stratistics MRC, the Global Oral Microbiome Market is accounted for $1.14 billion in 2026 and is expected to reach $3.71 billion by 2034 growing at a CAGR of 15.9% during the forecast period. The oral microbiome market focuses on understanding and modulating the complex ecosystem of microorganisms residing in the oral cavity to improve dental and systemic health. Scientific advances linking oral bacteria to conditions beyond gum disease including cardiovascular disorders, diabetes, and Alzheimer's are driving innovation in targeted therapeutics and diagnostics. This emerging field encompasses probiotic formulations, diagnostic testing, microbiome-based therapeutics, and specialized oral care products designed to maintain microbial balance.

Market Dynamics:

Driver:

Growing scientific evidence linking oral health to systemic diseases

Accumulating research establishing connections between oral microbiome composition and overall health conditions is expanding market relevance beyond dentistry. Studies demonstrating associations between periodontal pathogens and cardiovascular disease, adverse pregnancy outcomes, and respiratory infections create compelling reasons for consumers and healthcare providers to prioritize oral microbial balance. This broader health context elevates oral care from cosmetic concern to essential wellness practice, driving demand for products supporting beneficial bacterial populations. Healthcare professionals increasingly recommend microbiome-friendly oral care, expanding market reach through professional channels and medical endorsement.

Restraint:

Regulatory complexities in product classification

Uncertain regulatory pathways for oral microbiome products create significant market entry barriers and commercialization challenges. Products modulating microbial populations may face classification as cosmetics, dietary supplements, medical devices, or drugs depending on claims and formulations, each requiring different approval processes. This regulatory ambiguity increases development costs, extends time-to-market, and creates compliance risks for manufacturers. Inconsistent international regulations further complicate global commercialization strategies. Smaller innovators particularly struggle with navigating these complex requirements, potentially limiting product diversity and slowing overall market expansion despite strong scientific foundations and consumer interest.

Opportunity:

Integration of artificial intelligence in microbiome analysis

AI-powered platforms analyzing complex oral microbiome data present transformative opportunities for personalized oral care recommendations. Machine learning algorithms can identify microbial patterns associated with specific disease risks, enabling predictive diagnostics and targeted interventions. These technologies process vast datasets from sequencing and metabolomics to generate actionable insights for consumers and dental professionals. AI integration facilitates development of companion diagnostics for microbiome therapeutics and enables real-time treatment optimization. As computational capabilities advance and costs decrease, AI-driven personalized oral health solutions become accessible to broader populations, creating substantial market expansion opportunities.

Threat:

Skepticism from traditional dental professionals

Resistance from conventional dentistry practitioners threatens market adoption by influencing patient perceptions and treatment recommendations. Many dental professionals remain unfamiliar with microbiome science or skeptical of probiotic approaches to oral health, preferring established mechanical and chemical interventions. This skepticism limits professional endorsements and referrals that significantly influence patient acceptance of novel products. Without dental community support, microbiome products risk being perceived as unsubstantiated wellness trends rather than evidence-based therapeutic options, constraining market penetration and delaying integration into standard oral care protocols and professional recommendations.

Covid-19 Impact:

The COVID-19 pandemic heightened awareness of immune health and its connection to microbial balance, benefiting oral microbiome market interest. Consumers increasingly recognized oral cavity as entry point for pathogens, driving interest in products supporting oral immune defenses. Tele-dentistry expansion during lockdowns familiarized patients with remote oral health management, creating channels for microbiome-based product recommendations. However, pandemic-related disruptions to dental visits reduced professional sampling and recommendation opportunities temporarily. The lasting legacy includes sustained consumer interest in proactive oral health management and acceptance of digital health approaches supporting continued market growth.

The Oral Care Products segment is expected to be the largest during the forecast period

The Oral Care Products segment is expected to account for the largest market share during the forecast period, encompassing toothpastes, mouthwashes, and specialized formulations designed to support beneficial oral bacteria. These products integrate microbiome-friendly ingredients while maintaining traditional cleaning functions, allowing consumers to upgrade existing routines without behavioral changes. Major oral care brands have entered this segment through product line extensions, leveraging established distribution channels and consumer trust. The segment benefits from daily usage patterns and broad demographic appeal, ensuring sustained market leadership as microbiome science integrates into conventional oral care.

The Next-Generation Sequencing (NGS) segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Next-Generation Sequencing (NGS) segment is predicted to witness the highest growth rate, enabling comprehensive profiling of oral microbial communities with unprecedented accuracy and depth. NGS technology allows identification of bacterial species and strains associated with health and disease, supporting diagnostic applications and therapeutic development. Decreasing sequencing costs make this technology increasingly accessible for clinical and direct-to-consumer applications. Dental professionals utilize NGS-based testing for personalized treatment planning, while researchers employ these tools for microbiome discoveries. The segment's essential role in advancing both diagnostics and therapeutics drives exceptional growth.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share, supported by advanced dental healthcare infrastructure, high consumer awareness, and significant research investment. The region hosts leading microbiome research institutions and innovative startups commercializing scientific discoveries. Strong direct-to-consumer marketing channels and consumer willingness to adopt novel wellness products accelerate market penetration. Dental insurance coverage for preventive care and professional recommendations for microbiome-based products further drive adoption. Established relationships between researchers, clinicians, and manufacturers create an innovation ecosystem maintaining North America's dominant market position throughout the forecast period.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, driven by large populations, rising dental health awareness, and expanding middle-class access to premium oral care. Countries including China, Japan, and South Korea combine traditional appreciation for preventive health with rapid adoption of advanced wellness technologies. Increasing dental tourism and international exposure familiarize consumers with microbiome concepts. Government initiatives promoting preventive healthcare and rising healthcare expenditure support market infrastructure development. As international microbiome companies expand distribution partnerships and local manufacturers develop regionally relevant products, Asia Pacific emerges as the fastest-growing regional market.

Key players in the market

Some of the key players in Oral Microbiome Market include Colgate-Palmolive Company, Procter & Gamble Company, Johnson & Johnson, GlaxoSmithKline plc, Unilever PLC, 3M Company, Dentsply Sirona Inc., Kao Corporation, Lion Corporation, Sunstar Suisse S.A., Oragenics, Inc., BLIS Technologies Limited, Oral Biotech Ltd., Microbiome Insights Inc., and Viome Life Sciences, Inc.

Key Developments:

In January 2026, Colgate-Palmolive announced a new multi-year global partnership with the WHO Foundation to advance oral health. The initiative focuses on scaling preventive measures and education, recognizing oral diseases as a foundational public health priority linked to overall systemic health.

In July 2025, Haleon broke ground on a new £130 million Global Oral Health Innovation Centre in Weybridge, UK. This facility is dedicated to R&D in dental science, including the study of oral biofilms and their impact on systemic health.

In May 2025, Unilever scientists, in collaboration with the University of Liverpool, published a study in the British Journal of Dermatology regarding the microbiome-brain axis. While focused on skin, the company confirmed this research is being applied to its oral care portfolio (Zendium brand) to understand the link between oral bacteria and psychological wellbeing.

Product Types Covered:

  • Probiotic-Based Oral Products
  • Prebiotic Oral Products
  • Synbiotic Formulations
  • Oral Microbiome Diagnostics & Test Kits
  • Microbiome-Based Therapeutics
  • Oral Care Products
  • Dietary Supplements
  • Other Product Types

Technologies Covered:

  • Next-Generation Sequencing (NGS)
  • Metagenomics
  • Metatranscriptomics
  • Proteomics & Metabolomics
  • Bioinformatics & Microbiome Analytics
  • AI-Based Microbiome Modeling
  • Other Technologies

Applications Covered:

  • Dental Caries Prevention
  • Periodontal Diseases
  • Halitosis Management
  • Oral Cancer Detection & Risk Assessment
  • Systemic Disease Link
  • Personalized Oral Healthcare
  • Preventive Dentistry
  • Other Applications

End Users Covered:

  • Dental Clinics
  • Hospitals
  • Research & Academic Institutes
  • Diagnostic Laboratories
  • Pharmaceutical & Biotechnology Companies
  • Individual Consumers
  • Other End Users

Distribution Channels Covered:

  • Online Platforms
  • Pharmacies & Drug Stores
  • Dental Clinics & Hospitals
  • Specialty Stores
  • Direct-to-Consumer Channels
  • Other Distribution Channels

Demographics Covered:

  • Adults
  • Pediatrics
  • Geriatric Population

Regions Covered:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Spain
    • Netherlands
    • Belgium
    • Sweden
    • Switzerland
    • Poland
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Singapore
    • Vietnam
    • Rest of Asia Pacific
  • South America
    • Brazil
    • Argentina
    • Colombia
    • Chile
    • Peru
    • Rest of South America
  • Rest of the World (RoW)
    • Middle East
  • Saudi Arabia
  • United Arab Emirates
  • Qatar
  • Israel
  • Rest of Middle East
    • Africa
  • South Africa
  • Egypt
  • Morocco
  • Rest of Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

  • 1.1 Market Snapshot and Key Highlights
  • 1.2 Growth Drivers, Challenges, and Opportunities
  • 1.3 Competitive Landscape Overview
  • 1.4 Strategic Insights and Recommendations

2 Research Framework

  • 2.1 Study Objectives and Scope
  • 2.2 Stakeholder Analysis
  • 2.3 Research Assumptions and Limitations
  • 2.4 Research Methodology
    • 2.4.1 Data Collection (Primary and Secondary)
    • 2.4.2 Data Modeling and Estimation Techniques
    • 2.4.3 Data Validation and Triangulation
    • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

  • 3.1 Market Definition and Structure
  • 3.2 Key Market Drivers
  • 3.3 Market Restraints and Challenges
  • 3.4 Growth Opportunities and Investment Hotspots
  • 3.5 Industry Threats and Risk Assessment
  • 3.6 Technology and Innovation Landscape
  • 3.7 Emerging and High-Growth Markets
  • 3.8 Regulatory and Policy Environment
  • 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

  • 4.1 Porter's Five Forces Analysis
    • 4.1.1 Supplier Bargaining Power
    • 4.1.2 Buyer Bargaining Power
    • 4.1.3 Threat of Substitutes
    • 4.1.4 Threat of New Entrants
    • 4.1.5 Competitive Rivalry
  • 4.2 Market Share Analysis of Key Players
  • 4.3 Product Benchmarking and Performance Comparison

5 Global Oral Microbiome Market, By Product Type

  • 5.1 Probiotic-Based Oral Products
  • 5.2 Prebiotic Oral Products
  • 5.3 Synbiotic Formulations
  • 5.4 Oral Microbiome Diagnostics & Test Kits
  • 5.5 Microbiome-Based Therapeutics
  • 5.6 Oral Care Products
  • 5.7 Dietary Supplements
  • 5.8 Other Product Types

6 Global Oral Microbiome Market, By Technology

  • 6.1 Next-Generation Sequencing (NGS)
  • 6.2 Metagenomics
  • 6.3 Metatranscriptomics
  • 6.4 Proteomics & Metabolomics
  • 6.5 Bioinformatics & Microbiome Analytics
  • 6.6 AI-Based Microbiome Modeling
  • 6.7 Other Technologies

7 Global Oral Microbiome Market, By Application

  • 7.1 Dental Caries Prevention
  • 7.2 Periodontal Diseases
  • 7.3 Halitosis Management
  • 7.4 Oral Cancer Detection & Risk Assessment
  • 7.5 Systemic Disease Link
  • 7.6 Personalized Oral Healthcare
  • 7.7 Preventive Dentistry
  • 7.8 Other Applications

8 Global Oral Microbiome Market, By End User

  • 8.1 Dental Clinics
  • 8.2 Hospitals
  • 8.3 Research & Academic Institutes
  • 8.4 Diagnostic Laboratories
  • 8.5 Pharmaceutical & Biotechnology Companies
  • 8.6 Individual Consumers
  • 8.7 Other End Users

9 Global Oral Microbiome Market, By Distribution Channel

  • 9.1 Online Platforms
  • 9.2 Pharmacies & Drug Stores
  • 9.3 Dental Clinics & Hospitals
  • 9.4 Specialty Stores
  • 9.5 Direct-to-Consumer Channels
  • 9.6 Other Distribution Channels

10 Global Oral Microbiome Market, By Demographics

  • 10.1 Adults
  • 10.2 Pediatrics
  • 10.3 Geriatric Population

11 Global Oral Microbiome Market, By Geography

  • 11.1 North America
    • 11.1.1 United States
    • 11.1.2 Canada
    • 11.1.3 Mexico
  • 11.2 Europe
    • 11.2.1 United Kingdom
    • 11.2.2 Germany
    • 11.2.3 France
    • 11.2.4 Italy
    • 11.2.5 Spain
    • 11.2.6 Netherlands
    • 11.2.7 Belgium
    • 11.2.8 Sweden
    • 11.2.9 Switzerland
    • 11.2.10 Poland
    • 11.2.11 Rest of Europe
  • 11.3 Asia Pacific
    • 11.3.1 China
    • 11.3.2 Japan
    • 11.3.3 India
    • 11.3.4 South Korea
    • 11.3.5 Australia
    • 11.3.6 Indonesia
    • 11.3.7 Thailand
    • 11.3.8 Malaysia
    • 11.3.9 Singapore
    • 11.3.10 Vietnam
    • 11.3.11 Rest of Asia Pacific
  • 11.4 South America
    • 11.4.1 Brazil
    • 11.4.2 Argentina
    • 11.4.3 Colombia
    • 11.4.4 Chile
    • 11.4.5 Peru
    • 11.4.6 Rest of South America
  • 11.5 Rest of the World (RoW)
    • 11.5.1 Middle East
      • 11.5.1.1 Saudi Arabia
      • 11.5.1.2 United Arab Emirates
      • 11.5.1.3 Qatar
      • 11.5.1.4 Israel
      • 11.5.1.5 Rest of Middle East
    • 11.5.2 Africa
      • 11.5.2.1 South Africa
      • 11.5.2.2 Egypt
      • 11.5.2.3 Morocco
      • 11.5.2.4 Rest of Africa

12 Strategic Market Intelligence

  • 12.1 Industry Value Network and Supply Chain Assessment
  • 12.2 White-Space and Opportunity Mapping
  • 12.3 Product Evolution and Market Life Cycle Analysis
  • 12.4 Channel, Distributor, and Go-to-Market Assessment

13 Industry Developments and Strategic Initiatives

  • 13.1 Mergers and Acquisitions
  • 13.2 Partnerships, Alliances, and Joint Ventures
  • 13.3 New Product Launches and Certifications
  • 13.4 Capacity Expansion and Investments
  • 13.5 Other Strategic Initiatives

14 Company Profiles

  • 14.1 Colgate-Palmolive Company
  • 14.2 Procter & Gamble Company
  • 14.3 Johnson & Johnson
  • 14.4 GlaxoSmithKline plc
  • 14.5 Unilever PLC
  • 14.6 3M Company
  • 14.7 Dentsply Sirona Inc.
  • 14.8 Kao Corporation
  • 14.9 Lion Corporation
  • 14.10 Sunstar Suisse S.A.
  • 14.11 Oragenics, Inc.
  • 14.12 BLIS Technologies Limited
  • 14.13 Oral Biotech Ltd.
  • 14.14 Microbiome Insights Inc.
  • 14.15 Viome Life Sciences, Inc.

List of Tables

  • Table 1 Global Oral Microbiome Market Outlook, By Region (2023-2034) ($MN)
  • Table 2 Global Oral Microbiome Market Outlook, By Product Type (2023-2034) ($MN)
  • Table 3 Global Oral Microbiome Market Outlook, By Probiotic-Based Oral Products (2023-2034) ($MN)
  • Table 4 Global Oral Microbiome Market Outlook, By Prebiotic Oral Products (2023-2034) ($MN)
  • Table 5 Global Oral Microbiome Market Outlook, By Synbiotic Formulations (2023-2034) ($MN)
  • Table 6 Global Oral Microbiome Market Outlook, By Oral Microbiome Diagnostics & Test Kits (2023-2034) ($MN)
  • Table 7 Global Oral Microbiome Market Outlook, By Microbiome-Based Therapeutics (2023-2034) ($MN)
  • Table 8 Global Oral Microbiome Market Outlook, By Oral Care Products (2023-2034) ($MN)
  • Table 9 Global Oral Microbiome Market Outlook, By Dietary Supplements (2023-2034) ($MN)
  • Table 10 Global Oral Microbiome Market Outlook, By Other Product Types (2023-2034) ($MN)
  • Table 11 Global Oral Microbiome Market Outlook, By Technology (2023-2034) ($MN)
  • Table 12 Global Oral Microbiome Market Outlook, By Next-Generation Sequencing (NGS) (2023-2034) ($MN)
  • Table 13 Global Oral Microbiome Market Outlook, By Metagenomics (2023-2034) ($MN)
  • Table 14 Global Oral Microbiome Market Outlook, By Metatranscriptomics (2023-2034) ($MN)
  • Table 15 Global Oral Microbiome Market Outlook, By Proteomics & Metabolomics (2023-2034) ($MN)
  • Table 16 Global Oral Microbiome Market Outlook, By Bioinformatics & Microbiome Analytics (2023-2034) ($MN)
  • Table 17 Global Oral Microbiome Market Outlook, By AI-Based Microbiome Modeling (2023-2034) ($MN)
  • Table 18 Global Oral Microbiome Market Outlook, By Other Technologies (2023-2034) ($MN)
  • Table 19 Global Oral Microbiome Market Outlook, By Application (2023-2034) ($MN)
  • Table 20 Global Oral Microbiome Market Outlook, By Dental Caries Prevention (2023-2034) ($MN)
  • Table 21 Global Oral Microbiome Market Outlook, By Periodontal Diseases (2023-2034) ($MN)
  • Table 22 Global Oral Microbiome Market Outlook, By Halitosis Management (2023-2034) ($MN)
  • Table 23 Global Oral Microbiome Market Outlook, By Oral Cancer Detection & Risk Assessment (2023-2034) ($MN)
  • Table 24 Global Oral Microbiome Market Outlook, By Systemic Disease Link (2023-2034) ($MN)
  • Table 25 Global Oral Microbiome Market Outlook, By Personalized Oral Healthcare (2023-2034) ($MN)
  • Table 26 Global Oral Microbiome Market Outlook, By Preventive Dentistry (2023-2034) ($MN)
  • Table 27 Global Oral Microbiome Market Outlook, By Other Applications (2023-2034) ($MN)
  • Table 28 Global Oral Microbiome Market Outlook, By End User (2023-2034) ($MN)
  • Table 29 Global Oral Microbiome Market Outlook, By Dental Clinics (2023-2034) ($MN)
  • Table 30 Global Oral Microbiome Market Outlook, By Hospitals (2023-2034) ($MN)
  • Table 31 Global Oral Microbiome Market Outlook, By Research & Academic Institutes (2023-2034) ($MN)
  • Table 32 Global Oral Microbiome Market Outlook, By Diagnostic Laboratories (2023-2034) ($MN)
  • Table 33 Global Oral Microbiome Market Outlook, By Pharmaceutical & Biotechnology Companies (2023-2034) ($MN)
  • Table 34 Global Oral Microbiome Market Outlook, By Individual Consumers (2023-2034) ($MN)
  • Table 35 Global Oral Microbiome Market Outlook, By Other End Users (2023-2034) ($MN)
  • Table 36 Global Oral Microbiome Market Outlook, By Distribution Channel (2023-2034) ($MN)
  • Table 37 Global Oral Microbiome Market Outlook, By Online Platforms (2023-2034) ($MN)
  • Table 38 Global Oral Microbiome Market Outlook, By Pharmacies & Drug Stores (2023-2034) ($MN)
  • Table 39 Global Oral Microbiome Market Outlook, By Dental Clinics & Hospitals (2023-2034) ($MN)
  • Table 40 Global Oral Microbiome Market Outlook, By Specialty Stores (2023-2034) ($MN)
  • Table 41 Global Oral Microbiome Market Outlook, By Direct-to-Consumer Channels (2023-2034) ($MN)
  • Table 42 Global Oral Microbiome Market Outlook, By Other Distribution Channels (2023-2034) ($MN)
  • Table 43 Global Oral Microbiome Market Outlook, By Demographics (2023-2034) ($MN)
  • Table 44 Global Oral Microbiome Market Outlook, By Adults (2023-2034) ($MN)
  • Table 45 Global Oral Microbiome Market Outlook, By Pediatrics (2023-2034) ($MN)
  • Table 46 Global Oral Microbiome Market Outlook, By Geriatric Population (2023-2034) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.